Berberine and Exemestane Interaction

Avoid
Mechanism-based 64% confidence

Berberine and Exemestane have a potentially harmful interaction with 64% confidence. Both Berberine and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.

Compound Profiles

Berberine

Plant Alkaloid | Natural Glucose & Lipid Management

Berberine's primary mechanism of action involves activation of AMP-activated protein kinase (AMPK), the cell's master energy-sensing enzyme. Unlike metformin, which activates AMPK primarily through inhibition of mitochondrial Complex I, berberine appears to activate AMPK through multiple pathways, including direct inhibition of mitochondrial Complex I, stimulation of AMPK phosphorylation, and modulation of the AMP-to-ATP ratio.

Half-life: ~4 hours Typical dose: 500 mg 2-3x/day metabolic, longevity
ampkngf blood pressure raisinghepatotoxicinsulin disruptinginsulin sensitizing
View full profile

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Half-life: ~24 hours Typical dose: 12.5mg EOD or 25mg E3D (estrogen management) pct, anabolic
androgen receptoraromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pancreas
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Berberine, Exemestane). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds disrupt lipids (Berberine, Exemestane). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Berberine, Exemestane). Monitor accordingly.

Frequently Asked Questions

Can I take Berberine with Exemestane?

Combining Berberine with Exemestane is not recommended. Both Berberine and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Berberine and Exemestane safe together?

This combination carries significant risk. Both Berberine and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Berberine and Exemestane?

Both Berberine and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Berberine and Exemestane?

Berberine has a half-life of ~4 hours and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Berberine vs Exemestane

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.